Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oroxid for oral care in mechanically ventilated patients
NCT06045429Phase 4Recruiting
- Sponsor
- Charles University
- Start
- May 2024
- Primary completion
- Jun 2025
- Modality
- Transdermal Patches, DNA Intercalators/Alkylators, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 4 trial of oroxid in ventilator-associated pneumonia (VAP), sponsored by Charles University. Started May 2024; status: recruiting.
02
Drugs
oroxid
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT06045429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06045429.